Advertisement
Entyvio
Specialty Drug

Vedolizumab

VEDOLIZUMAB (Ve doe LIZ you mab) is used to treat ulcerative colitis and Crohn's disease in adult patients. Compare integrin antagonists.
Advertisement

Entyvio Latest News

Get the latest updates on this drug from the GoodRx medical team

Entyvio Now Approved for Ulcerative Colitis and Crohn’s

The GoodRx Pharmacist - May 28, 2014

Entyvio (vendolizumab) was approved by the FDA on May 20, 2014 for the treatment of ulcerative colitis and Crohn’s disease in patients where other treatments have not worked or cannot be tolerated.

What are ulcerative colitis and Crohn’s disease, and how do they differ?

Ulcerative colitis and Crohn’s are branches of a larger umbrella term known as inflammatory bowel disease (IBD). Ulcerative colitis is the inflammation of the lining of the large intestine (colon) and rectum. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.